References:
1.(https://pathology.jhu.edu/autoimmune/prevalence)
( john hopkin’s medicine)
2. Conor Fearon, Orna O’Toole.Autoimmune Movement
Disorders. Semin Neurol 2018; 38:316–329.
3. Honorat JA, McKeon A: Autoimmune movement
disorders: a clinical and laboratory approach. Curr
Neurol Neurosci Rep. 2017;17(1):4. doi:
10.1007/s11910-017-0709-2.
4. Jones AL, Flanagan EP, Pittock SJ, et al. Responses
to and outcomes of treatment of autoimmune
cerebellar ataxia in adults. JAMA Neurol.
2015;72(11):1304–1312. doi:10.1001/
jamaneurol.2015.2378.)
5. Lauret E, Rodrigo .Celiac Disease and
Autoimmune-Associated Conditions. BioMed Research
International Volume2013,Article ID 127589, 17
pages http://dx.doi.org/10.1155/2013/127589.
6. https://doi.org/10.14802/jmd.16063 / J Mov
Disord 2017;10(2):105-107 pISSN 2005-940X /
eISSN 2093-493)
7.Donaldson I, Marsden CD,Schneider S. Marsden’s
Book of Movement Disorders. Oxford: Oxford University
Press; 2012.
8 . Baizabal-Carvallo JF, Jankovic J .Autoimmune
and paraneoplastic movement disorders: An
update. REVIEW ARTICLE| VOLUME 385,
P175-184, FEBRUARY 15, 2018.
DOI:https://doi.org/10.1016/j.jns.2017.12.035
9 . Gövert F, Leypoldt F , Wandinger KP et al.
Antibody-related movement disorders – a
comprehensive review of phenotype autoantibody
correlations and a guide to testing Neurological
Research and Practice (2020) 2:6
https://doi.org/10.1186/s42466-020-0053-x
10.American academy of neurology ( April 09, 2019;
92 (15 Supplement) MAY 6, 2019) .
11.F.Cataldo and V.Marino, “Increased prevalence of
autoimmune diseases in first-degree relatives of
patients with celiac disease,” Journal of Pediatric
Gastroenterology and Nutrition,vol.36,no.
4,pp.470–473,2003.
12. M. Viljamaa, K. Kaukinen, H. Huhtala, S.
Kyr¨onpalo, M. Rasmussen, and P. Collin, “Coeliac
disease, autoimmune diseases and gluten
exposure,”Scandinavian Journal of Gastroenterology,
vol.40,no.4,pp.437–443,2005.
13. S. L. Neuhausen, L. Steele, S. Ryan et al.,
“Co-occurrence of celiac disease and other
autoimmune diseases in celiacs and their first-degree
relatives,” Journal of Autoimmunity,vol.31, no.
2,pp.160–165,2008.
14. P. Collin, T. Reunala, E. Pukkala, P. Laippala, O.
Keyril¨ainen, and A. Pasternack, “Coeliac
disease—associated disorders and
survival,”Gut,vol.35,no.9,pp.1215–1218,1994.
15. A. Fasano, I. Berti, T. Gerarduzzi et al.,
“Prevalence of Celiac disease in at-risk and
not-at-risk groups in the United States : a large
multicentre study, ”Archives of Internal
Medicine,vol.163, no.3,pp.286–292,2003.
16 .J. Cosnes, C. Cellier, S. Viola et al., “Incidence of
autoimmune diseases in celiac disease: protective
effect of the gluten-free diet,” Clinical
Gastroenterology and Hepatology,vol.6,no.7,pp.
753–758,2008.
PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES
33
VOL. 15 (2) APRIL-JUNE 2020
In 2017, “Isolated Neurological Manifestation in Silent Celiac Disease” was published in which a case of idiopathic
oromandibular dystonia (OMD) is discussed that was unresponsive to traditional symptomatic therapy. However,
complete resolution of symptoms was obtained after celiac disease (CD) diagnosis and gluten free diet
6
. In the same
way, our case 1 patient also showed the improvement. Association of asymptomatic high creatine phosphokinase
(CPK) level and celiac disease or other neurological illnesses remains unexplained except for the limited clue due to
its types CK MM, CK BB, and CK MB. Further studies are highly recommended to clarify the unexplained factors and
further management of such cases.
CONCLUSION:
Isolated autoimmune movement disorders are uncommon and are usually associated with other neurological features.
A prompt and thorough work up for an underlying cause and associated neural or systemic antibodies in such
suspected cases. Ultimately through this approach decisions can be easily taken for the treatment and prognosis of
disease. Further studies are direly needed to clarify the issues encountered in management of such cases.